News
"Nucleic Acid Therapeutics welcomes this fine addition to the armamentarium of bioanalytical assays needed to identify ...
Rona Therapeutics, a biotechnology company pioneering innovative RNA-targeted therapies, announced that the Investigational New Drug (IND) application for RN1871, a small interfering RNA (siRNA) drug ...
Our research aims to develop and utilise nucleic acid therapeutics for new and effective therapies targeting disease, but also to improve the efficiency of our manufacturing processes and analytical ...
A company that is working on advancing non-viral delivery technologies for nucleic acid therapeutics, such as mRNA, small interfering ribonucleic acid (siRNA), and antisense oligonucleotides (ASOs ...
Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; "Ono") announced that it has entered into a research collaboration agreement with Jorna Therapeutics ...
Prof Rory Johnson, Associate Professor, University College Dublin, and Dr Shalini Andersson, Vice President Nucleic Acid Therapeutics, AstraZeneca will lead this year's event focused on 'drugging ...
Numerous nucleic acid-based therapies are under development ... contributors to cancer initiation and growth.” About Revive Therapeutics Ltd. Revive Therapeutics is a life sciences company ...
Exicure to initiate new clinical trial in acute myeloid leukaemia with GPC-100: Redwood City, California Tuesday, April 15, 2025, 18:00 Hrs [IST] Exicure, Inc., an early-stage bio ...
The Global Nucleic Acid Isolation and Purification Market is segmented into drug discovery & development, precision medicine, diagnostics, agriculture and animal research, and other, based on ...
Southern RNA is an Australian CDMO specialising in producing nucleic acid products that support the clinical development of ...
Revive Therapeutics Ltd. ("Revive" or the "Company") (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results